Thryv Therapeutics' CEO, Paul Truex, to Present at Piper Sandler's 35th Annual Healthcare Conference

• Paul Truex to present Wednesday, November 29^th at 3:50-4:10PM in Harlem Track, Kennedy 2, 4^th floor.

MONTREAL, Nov. 10, 2023 /CNW/ - Thryv Therapeutics is pleased to announce its selection as a featured presenter at the Piper Sandler 35^th Annual Healthcare Conference, held from November 28^th to November 30^th, 2023, at Lotte New York Palace in New York City. Paul Truex, Thryv's Chairman of the Board & Chief Executive Officer, will present on November 29^th from 3:50 to 4:10 PM in Harlem Track, Kennedy 2, 4^th floor.

Mr. Truex will also be available for one-on-one meetings on Wednesday, November 29th. To book one-on-one meetings, please contact [email protected].

About Thryv Therapeutics Inc.

Thryv Therapeutics Inc. (previously LQT Therapeutics Inc.) is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat Congenital Long QT Syndromes (LQTS), atrial fibrillation, heart failure and resistant cancers with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase (SGK1). For more information, please visit www.thryvtrx.com.

SOURCE Thryv Therapeutics Inc.

Media Inquiries: [email protected] | 514 973 0915